e.l.f. Beauty (ELF)
(Delayed Data from NYSE)
$172.57 USD
-10.25 (-5.61%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $172.61 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Income Statements
Fiscal Year end for elf Beauty falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 1,024 | 579 | 392 | 318 | 283 |
Cost Of Goods | 300 | 188 | 140 | 112 | 102 |
Gross Profit | 724 | 390 | 252 | 206 | 181 |
Selling & Adminstrative & Depr. & Amort Expenses | 574 | 322 | 222 | 197 | 151 |
Income After Depreciation & Amortization | 150 | 68 | 30 | 9 | 30 |
Non-Operating Income | -2 | -2 | -2 | -2 | 0 |
Interest Expense | 7 | 2 | 2 | 4 | 6 |
Pretax Income | 141 | 64 | 25 | 4 | 24 |
Income Taxes | 13 | 3 | 4 | -3 | 6 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 128 | 62 | 22 | 6 | 18 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 128 | 62 | 22 | 6 | 18 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 186 | 91 | 57 | 35 | 54 |
Depreciation & Amortization (Cash Flow) | 36 | 23 | 27 | 26 | 24 |
Income After Depreciation & Amortization | 150 | 68 | 30 | 9 | 30 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 57.79 | 55.34 | 53.65 | 51.99 | 50.82 |
Diluted EPS Before Non-Recurring Items | 2.59 | 1.24 | 0.55 | 0.42 | 0.42 |
Diluted Net EPS (GAAP) | 2.21 | 1.11 | 0.41 | 0.12 | 0.35 |
Fiscal Year end for elf Beauty falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 321.14 | 270.94 | 215.51 | 216.34 |
Cost Of Goods | NA | 93.94 | 78.99 | 63.14 | 63.77 |
Gross Profit | NA | 227.20 | 191.96 | 152.37 | 152.57 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 210.17 | 160.12 | 112.19 | 91.94 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 17.03 | 31.84 | 40.18 | 60.63 |
Non-Operating Income | NA | -1.85 | 2.57 | -1.06 | -1.32 |
Interest Expense | NA | 4.00 | 3.99 | -0.62 | -0.34 |
Pretax Income | NA | 11.18 | 30.42 | 39.74 | 59.65 |
Income Taxes | NA | -3.35 | 3.53 | 6.47 | 6.68 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 14.53 | 26.89 | 33.27 | 52.98 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 14.53 | 26.89 | 33.27 | 52.98 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 58.49 | 58.03 | 57.44 | 57.18 |
Diluted EPS Before Non-Recurring Items | NA | 0.37 | 0.58 | 0.66 | 1.00 |
Diluted Net EPS (GAAP) | NA | 0.24 | 0.46 | 0.58 | 0.93 |